Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Understanding on India’s Revised Patent Rules On Priority filing w.e.f 19 October, 2020
The Indian Patent office has issued a notification that the Patents (Amendment) Rules, 2020, was released and enforced on 19 October, 2020.... Read More
Insight of BioInvent’s licensing deal of anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals
BioInvent licenses anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals for Greater China region. BioInvent have entered into an exclusive licensing agreement for the... Read More
Insight on Veklury’s clinical and strategic pathway for USFDA approval for Covid-19
Posted on24 Oct 2020
TagsCOVID-19, priority review, Priority Review Designation, Remdesivir, usfda, usfda accelerated approval, USFDA Priority Review, Veklury
Comments0
USFDA approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at... Read More
Case Study: Rinvoq’s brand Dermatology market expansion strategy
Rinvoq is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. Rinvoq is the brand of... Read More
AbbVie’s Elezanumab receives US FDA orphan drug and fast track designations
Posted on30 Sep 2020
Comments0
AbbVie announced that the US Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an... Read More
USFDA granted expanded access to investigational ERK inhibitor ulixertinib
The US Food and Drug Administration has granted expanded access to BioMed Valley Discoveries’ investigational ERK inhibitor ulixertinib for patients with cancers... Read More
Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine
Aurobindo Pharma is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a... Read More
Insight on First approved COVID-19 vaccine Sputnik V
Posted on11 Aug 2020
Comments0
Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed... Read More
Lupin gets exclusive rights to market and distribute 2 complex injectable assets from ForDoz Pharma
Pharma major Lupin Limited announced that its US based wholly-owned subsidiary Lupin Pharmaceuticals Inc., has entered into an agreement with ForDoz Pharma... Read More